Drug hunters are finding that ancient virus-like artifacts in the human genome could offer new avenues to treat neurodegeneration, cancer, autoimmunity and even aging with antibodies, vaccines and antiretroviral agents.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
25 April 2024
In the version of the article initially published, the drug name TPN-101 originally appeared as TPN-01. Additionally, Peter Holst was listed as the CEO of Hervolution which has now been corrected to CSO.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eisenstein, M. Startups probe hidden viruses in the ‘dark genome’ to treat disease. Nat Biotechnol 42, 539–541 (2024). https://doi.org/10.1038/s41587-024-02215-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-024-02215-1
